Seven Eight Capital »

Morphic Hldg shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Morphic Hldg (MORF) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Morphic Hldg

Tip: Access up to 7 years of quarterly data

All positions including Morphic Hldg held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Morphic Hldg by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 51k 22.91

More positions owned by Seven Eight Capital

Edwards Lifesciences (EW)
Merck & Co (MRK)
Las Vegas Sands (LVS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertiv Holdings Com Cl A (VRT)
Intuitive Surgical Com New (ISRG)
ResMed (RMD)
Docusign (DOCU)
Fiserv (FI)
Xylem (XYL)
Meta Platforms Cl A (META)
Jabil Circuit (JBL)
Nextera Energy (NEE)

View all positions for Seven Eight Capital

Top funds holding Morphic Hldg

Point72 Asset Management
Wellington Management Company
Vanguard Group
T. Rowe Price Associates
Artal Group
Federated Investors
Goldman Sachs Group
Jennison Associates
Two Sigma Advisers
Two Sigma Investments
Marshall Wace
Charles Schwab Investment Management
Omega Fund Management
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Morphic Hldg